J. H. Doroshow - Concepedia

Author

J. H. Doroshow

City Of Hope National Medical Center

Also Known As

J Doroshow, J H Doroshow, J. Doroshow, J. H. Doroshow, J.H. Doroshow, James Doroshow, James H. Doroshow

Publications

715

Citations

H-Index

Concepts

All Affiliations

City Of Hope National Medical Center City of Hope University of California, San Francisco Albert Einstein College of Medicine University of Chicago

About

J. H. Doroshow is an author at City Of Hope National Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	280
2	Health Sciences	3	3	36
3	Cell Biology	1	1	23
4	Head And Neck Surgery	1	1	43
5	Hepatology	1	1	15

J. H. Doroshow

Publications

587

Citations

H-Index

Page 1

	Year	Citations
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies. Wong JYC, David Z. J. Chu, Dave Yamauchi, PubMed ImmunologyImmunoediting90Yttrium-labeled Anti-carcinoembryonic AntigenImmunotherapyStable Disease	2000	87
Phase II Studies of Recombinant Human Interleukin-4 in Advanced Renal Cancer and Malignant Melanoma Kim Margolin, Frederick R. Aronson, Mario Sznol, Journal of Immunotherapy	1994	69
HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase II Leonard A. Zwelling, Marilyn L. Slovak, J. H. Doroshow, JNCI Journal of the National Cancer Institute	1990	58
Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable Malignant Melanoma and Renal Cell Carcinoma Ellen R. Gaynor, Geoffrey R. Weiss, Kim Margolin, JNCI Journal of the National Cancer Institute	1990	47
Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis Patricia S. Braly, J. H. Doroshow, Sheila Hoff Gynecologic Oncology Surgical OncologyGastrointestinal OncologyMedicineAbdominal CarcinomatosisSurgery	1986	43
Multicenter phase II trial of brequinar sodium in patients with advanced squamous-cell carcinoma of the head and neck Susan G. Urba, J. H. Doroshow, C. Cripps, Cancer Chemotherapy and Pharmacology MedicineBrequinar SodiumAdvanced Squamous-cell CarcinomaPathologyHead And Neck Cancer	1992	43
Effect of CD34+ Selection and Various Schedules of Stem Cell Reinfusion and Granulocyte Colony-Stimulating Factor Priming on Hematopoietic Recovery After High-Dose Chemotherapy for Breast Cancer George Somlo, Irena Sniecinski, Tamara Odom‐Maryon, Blood	1997	43
Phase II trial of cisplatin and alpha-interferon in advanced malignant melanoma. Kim Margolin, J. H. Doroshow, Steven A. Akman, Journal of Clinical Oncology	1992	31
Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial. George Somlo, J. H. Doroshow, Arye Lev-Ran, Journal of Clinical Oncology	1995	26
CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute Gabriele Zoppoli, Stéphanie Solier, William C. Reinhold, Oncogene Cell RegulationGenetic InactivationProteomic AnalysesMedicineCancer Cell Biology	2011	23

Page 1